Category: Politics

CNBC: Why drug prices are so difficult to bring down

This article was originally posted by Kari Firestone’s newest article discusses why the incentives for companies and research organizations may not be aligned with customers’ desire for lower drug prices. Additionally, the legal complexity of the Medicare system leaves the government with no negotiating power, further inflating prescription drug prices. Read the full article…


NYT: A Drug Costs $272,000 a Year. Not So Fast, Says New York State.

It’s time for courts to weigh in on the issue of drug pricing.  As an investor, we want drug companies to earn a strong return on their investment – but using the “value of a life” thesis to justify price is too arbitrary as that might be infinite. Read the full article in The New…


HBR: Political Diversity as the Next Frontier

My newest piece focuses on political diversity in the workplace. In a country more polarized than perhaps at any other time in history, it’s still important to avoid political homogeneity in the workplace. In addition, I offers some principles I’ve used as a boss for smoothly navigating political discussions. Read the full story in The Harvard…